Arvinas Inc (ARVN)

Dec 10, 2025

Velan Capital Investment Management LP Takes Position in Arvinas, Inc. $ARVN - MarketBeat

Dec 10, 2025

Dec 10, 2025

Diadema Partners LP Invests $710,000 in Arvinas, Inc. $ARVN - MarketBeat

Dec 10, 2025

Dec 08, 2025

Arvinas reveals promising preclinical data for ARV-393 - MSN

Dec 08, 2025

Dec 08, 2025

Arvinas Reveals Promising Preclinical Data for ARV-393 - TipRanks

Dec 08, 2025

Dec 08, 2025

Arvinas, Inc. Announces Preclinical Data for ARV-393 Combination - TradingView

Dec 08, 2025

Dec 08, 2025

22NW LP Acquires Shares of 413,533 Arvinas, Inc. $ARVN - MarketBeat

Dec 08, 2025

Dec 07, 2025

Arvinas (ARVN) Reveals Promising Preclinical Data for Cancer Tre - GuruFocus

Dec 07, 2025

Dec 06, 2025

Published on: 2025-12-06 23:24:37 - BỘ NỘI VỤ

Dec 06, 2025

Dec 06, 2025

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition - The Manila Times

Dec 06, 2025

Dec 06, 2025

Arvinas, Inc. Announces Phase 1 Clinical Trial Initiation for ARV-393 Plus Glofitamab in Diffuse Large B-Cell Lymphoma Following Promising Preclinical Data - Quiver Quantitative

Dec 06, 2025

Dec 05, 2025

Why Arvinas Inc. stock could benefit from AI revolutionProfit Target & AI Forecasted Stock Moves - Newser

Dec 05, 2025

Dec 05, 2025

Franklin Resources Inc. Grows Stake in Arvinas, Inc. $ARVN - MarketBeat

Dec 05, 2025

Dec 04, 2025

Why Arvinas Inc. stock is considered a top pickBear Alert & Momentum Based Trading Signals - Newser

Dec 04, 2025

Dec 04, 2025

ARVN: Robust clinical pipeline advances and strong cash position support growth into 2028 - TradingView

Dec 04, 2025

Dec 04, 2025

Will Arvinas Inc. stock continue upward momentumIPO Watch & Weekly Watchlist for Hot Stocks - Newser

Dec 04, 2025

Dec 03, 2025

Arvinas (ARVN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 03, 2025

Dec 02, 2025

How the Narrative Around Arvinas Is Shifting Amid Strategic Moves and Analyst Uncertainty - Yahoo Finance

Dec 02, 2025

Nov 30, 2025

52,980 Shares in Arvinas, Inc. $ARVN Acquired by SG Americas Securities LLC - MarketBeat

Nov 30, 2025

Nov 28, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Arvinas, Inc. (ARVN - The National Law Review

Nov 28, 2025

Nov 28, 2025

New Highs: Why Arvinas Inc. stock remains on buy listsJuly 2025 Update & Accurate Intraday Trade Tips - BỘ NỘI VỤ

Nov 28, 2025

Nov 28, 2025

Entropy Technologies LP Purchases Shares of 32,491 Arvinas, Inc. $ARVN - MarketBeat

Nov 28, 2025

Nov 28, 2025

Arvinas Inc Stock Analysis and ForecastLow Beta Stocks & Outstanding Investment Returns - earlytimes.in

Nov 28, 2025

Nov 26, 2025

Published on: 2025-11-27 09:33:44 - BỘ NỘI VỤ

Nov 26, 2025

Nov 26, 2025

Arvinas (Nasdaq: ARVN) plans fireside chat at Piper Sandler 37th Healthcare Conference - Stock Titan

Nov 26, 2025

Nov 26, 2025

Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire

Nov 26, 2025

Nov 24, 2025

Arvinas to present vepdegestrant breast cancer data at SABCS By Investing.com - Investing.com Nigeria

Nov 24, 2025

Nov 24, 2025

Arvinas to present vepdegestrant breast cancer data at SABCS - Investing.com

Nov 24, 2025

Nov 24, 2025

Arvinas, Inc. Announces Multiple Abstract Presentations on Vepdegestrant at San Antonio Breast Cancer Symposium 2025 - Quiver Quantitative

Nov 24, 2025

Nov 24, 2025

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development ... - Enidnews.com

Nov 24, 2025

Nov 24, 2025

Arvinas Announces Data Presentations from the Vepdegestrant - GlobeNewswire

Nov 24, 2025

Nov 24, 2025

Arvinas: Approvable, But Asset Looks Mediocre, Initiating With A Hold Rating (NASDAQ:ARVN) - Seeking Alpha

Nov 24, 2025

Nov 21, 2025

Promising Biotech Stocks To ConsiderNovember 18th - MarketBeat

Nov 21, 2025

Nov 21, 2025

Can Arvinas Inc. stock beat market expectations this quarterTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com

Nov 21, 2025

Nov 20, 2025

Arvinas (NASDAQ:ARVN) Stock Price Down 7%Should You Sell? - MarketBeat

Nov 20, 2025

Nov 20, 2025

Why Arvinas Inc. stock attracts high net worth investorsRate Cut & High Win Rate Trade Tips - newser.com

Nov 20, 2025

Nov 20, 2025

Is Arvinas Inc. stock attractive after correctionJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

Connor Clark & Lunn Investment Management Ltd. Takes Position in Arvinas, Inc. $ARVN - MarketBeat

Nov 20, 2025

Nov 19, 2025

Arvinas Inc. stock chart pattern explainedSell Signal & Technical Pattern Recognition Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is Arvinas Inc. still worth holding after the dipFed Meeting & Target Return Focused Stock Picks - newser.com

Nov 19, 2025

Nov 19, 2025

Arvinas Inc. (ARVN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 19, 2025

Nov 19, 2025

Is Arvinas Inc. stock a top pick in earnings seasonJuly 2025 Earnings & Long-Term Safe Return Strategies - newser.com

Nov 19, 2025

Nov 19, 2025

Reversal indicators forming on Arvinas Inc. stockWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com

Nov 19, 2025

Nov 19, 2025

How Arvinas Inc. stock benefits from strong dollarForecast Cut & Real-Time Market Trend Scan - newser.com

Nov 19, 2025

Nov 19, 2025

Can Arvinas Inc. stock beat analyst upgradesQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Arvinas (NASDAQ:ARVN) Shares Gap UpShould You Buy? - MarketBeat

Nov 19, 2025

Nov 19, 2025

Can technical indicators confirm Arvinas Inc.’s reversalJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025